Richard Hazen
Texas Health Harris Methodist Hospital Fort Worth(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Biochemical and Molecular Research, Pneumocystis jirovecii pneumonia detection and treatment, HIV/AIDS Research and Interventions
Most-Cited Works
- → In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor(2010)372 cited
- → Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor(2005)168 cited
- → Application of Phosphoramidate Pronucleotide Technology to Abacavir Leads to a Significant Enhancement of Antiviral Potency(2005)94 cited
- → Design of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase with Improved Drug Resistance Properties. 1.(2004)90 cited
- → Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385(2006)78 cited
- → Reversible inhibition of cyclic AMP-dependent protein kinase by insulin(1978)78 cited
- → Structural Basis for the Improved Drug Resistance Profile of New Generation Benzophenone Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors(2008)77 cited
- → The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral(2007)74 cited
- → Novel inhibitors of HIV protease(2000)73 cited
- → Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1(2004)65 cited